1. Genetic tests
  2. Response to antiviral treatment in hepatitis C - IL28B genotyping (rs8099917 (T>G) + rs12979860 (C>T)) - Pharmacogenetics

Response to antiviral treatment in hepatitis C - IL28B genotyping (rs8099917 (T>G) + rs12979860 (C>T)) - Pharmacogenetics

Genetic test Export to PDF
Full name:
Response to antiviral treatment in hepatitis C - IL28B genotyping (rs8099917 (T>G) + rs12979860 (C>T)) - Pharmacogenetics
Test type:
Clinical
Test specialty:
Molecular Genetics
Test purpose:
Therapeutic Management
Specimen:
Peripheral (whole) blood on EDTA
Method category:
Targeted variant analysis
Method technique:
Real-time PCR
Laboratory:
Centre de Génétique Médicale UCL
RIZIV code:
565390-565401
EQA:
  • 2015 Molecular genetics group 2-SET F DGKL/RfB-Reference Institute for Bioanalytics
  • 2016 Molecular genetics group 2-SET F DGKL/RfB-Reference Institute for Bioanalytics
  • 2017 Molecular genetics group 2-SET F DGKL/RfB-Reference Institute for Bioanalytics
  • 2018 Molecular genetics group 2-SET F DGKL/RfB-Reference Institute for Bioanalytics
  • 2019 Molecular genetics group 2-SET F DGKL/RfB-Reference Institute for Bioanalytics
  • 2020 Molecular genetics group 2-SET F DGKL/RfB-Reference Institute for Bioanalytics
Turnaround time (maximum):
2 weeks
Document(s):
Created:
25 Jul 2019 - 17:44
Changed:
17 Feb 2022 - 14:49